THC
Tenet Healthcare Corporation (NYSE)
Healthcare — Medical Care Facilities
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Price History
Fundamentals
| Market Cap | $16.65B |
| P/E Ratio (TTM) | 10.05 |
| Forward P/E | 10.91 |
| EPS (TTM) | $19.23 |
| Dividend Yield | - |
| Profit Margin | 7.94% |
| Revenue Growth | 2.80% |
| ROE | 30.29% |
| Debt/Equity | 149.25 |
| Recommendation | Strong Buy 1.5 |
| Analyst Target | $243.19 |
| Analysts | 21 |
| Indexes | NYSE |
Technical Indicators
| RSI (14) | 71.9 |
| Beta | 1.28 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $247.21 |
| 52-Week Low | $146.60 |
| 50-Day Avg | $181.34 |
| 200-Day Avg | $198.48 |
| Avg Volume | $1.47M |
| Volume | 10.2K |
Performance Analysis
BULLISHTHC shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:34 UTC
Back to Screener Export Report